Tubular nephrotoxicity induced by docetaxel in non-small-cell lung cancer patients

被引：20
|
作者：
Takimoto, Takayuki [1 ]
Nakabori, Tasuku [1 ]
Osa, Akio [1 ]
Morita, Satomu [1 ]
Terada, Haruko [1 ]
Oseto, Susumu [1 ]
Iwazawa, Takashi [2 ]
Abe, Kinya [1 ]
机构：
[1] Toyonaka City Hosp, Dept Internal Med, Toyonaka, Osaka 5608565, Japan
[2] Toyonaka City Hosp, Dept Surg, Toyonaka, Osaka 5608565, Japan
来源：
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 17卷 / 04期
关键词：
Non-small-cell lung cancer (NSCLC); Chronic renal failure; Docetaxel; Tubular nephrotoxicity; beta(2)-Microglobulin; RENAL-FUNCTION; CISPLATIN; CHEMOTHERAPY; PLATINUM; TAXOTERE;
D O I：
10.1007/s10147-011-0304-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Renal dysfunction is a characteristic of many patients with cancer; however, a standard therapy has not been established for stage III or IV non-small-cell lung cancer (NSCLC) complicated with chronic renal failure. Docetaxel has a proven significant activity against NSCLC. This agent is predominantly eliminated by hepatobiliary extraction and is safe in patients with renal failure, including dialysis patients. Docetaxel is, thus, a therapeutic option in that patient population. Here, we report acute tubular nephrotoxicity secondary to docetaxel in NSCLC patients, even in patients with normal renal function. Little is known about tubular nephrotoxicity induced by docetaxel; however, oncologists should be aware of its possibility.
引用
收藏
页码：395 / 398
页数：4
相关论文
共 50 条
  • [21] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Borghaei, H.
    Paz-Ares, L.
    Horn, L.
    Spigel, D. R.
    Steins, M.
    Ready, N. E.
    Chow, L. Q.
    Vokes, E. E.
    Felip, E.
    Holgado, E.
    Barlesi, F.
    Kohlhaeufl, M.
    Arrieta, O.
    Burgio, M. A.
    Fayette, J.
    Lena, H.
    Poddubskaya, E.
    Gerber, D. E.
    Gettinger, S. N.
    Rudin, C. M.
    Rizvi, N.
    Crino, L.
    Blumenschein, G. R.
    Antonia, S. J.
    Dorange, C.
    Harbison, C. T.
    Finckenstein, F. Graf
    Brahmer, J. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17): : 1627 - 1639
  • [22] A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer
    Teramoto, Koji
    Asada, Yoshikuni
    Ozaki, Yoshitomo
    Suzumura, Yuji
    Nakano, Yasutaka
    Sawai, Satoru
    Tezuka, Noriaki
    Inoue, Shuhei
    Fujino, Shozo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 531 - 537
  • [23] Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer
    Katayama, H
    Ueoka, H
    Kiura, K
    Tabata, M
    Kozuki, T
    Tanimoto, M
    Fujiwara, T
    Tanaka, N
    Date, H
    Aoe, M
    Shimizu, N
    Takemoto, M
    Hiraki, Y
    BRITISH JOURNAL OF CANCER, 2004, 90 (05) : 979 - 984
  • [24] Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer
    H Katayama
    H Ueoka
    K Kiura
    M Tabata
    T Kozuki
    M Tanimoto
    T Fujiwara
    N Tanaka
    H Date
    M Aoe
    N Shimizu
    M Takemoto
    Y Hiraki
    British Journal of Cancer, 2004, 90 : 979 - 984
  • [25] Chemoradiotherapy followed by docetaxel may increase life expectancy in non-small-cell lung cancer patients
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 222 - 223
  • [26] A phase II study of oxaliplatin and docetaxel in patients with advanced non-small-cell lung cancer (NSCLC)
    Raez, L
    Santos, E
    Rocha-Lima, C
    Roman, E
    Kumar, P
    Farfan, N
    Decesare, T
    Lopes, G
    Rosado, M
    Wu, J
    LUNG CANCER, 2005, 49 : S265 - S265
  • [27] A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer
    Koji Teramoto
    Yoshikuni Asada
    Yoshitomo Ozaki
    Yuji Suzumura
    Yasutaka Nakano
    Satoru Sawai
    Noriaki Tezuka
    Shuhei Inoue
    Shozo Fujino
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 531 - 537
  • [28] Non-Small-Cell Lung Cancer
    不详
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (20): : 61 - 61
  • [29] Non-small-cell lung cancer
    Cesare Gridelli
    Antonio Rossi
    David P. Carbone
    Juliana Guarize
    Niki Karachaliou
    Tony Mok
    Francesco Petrella
    Lorenzo Spaggiari
    Rafael Rosell
    Nature Reviews Disease Primers, 1
  • [30] Non-small-cell lung cancer
    Gridelli, Cesare
    Rossi, Antonio
    Carbone, David P.
    Guarize, Juliana
    Karachaliou, Niki
    Mok, Tony
    Petrella, Francesco
    Spaggiari, Lorenzo
    Rosell, Rafael
    NATURE REVIEWS DISEASE PRIMERS, 2015, 1
12345